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Available online 28 May 2016 Organophosphate (OP) insecticides are commonly used in agriculture. Their use decreased in recent years as they 
were gradually replaced by other pesticides, but some OPs are still among the insecticides most used in Canada. 
Exposure to elevated levels of OPs during pregnancy has been associated with adverse birth outcomes and poorer 
neurodevelopment in children. The objective of the present study was to examine the relationship between the 
concentrations of OP pesticides urinary dialkyl phosphate (DAP) metabolites and various factors that are poten­
tial sources of exposure or determinants of DAP levels. In the Maternal-Infant Research on Environmental 
Chemicals (MIREC) Study, six DAPs were measured in 1st trimester urine samples of 1884 pregnant women liv­
ing in Canada. They were grouped into sums of dimethyl alkyl phosphates (DMAP) and diethyl alkyl phosphates 
(DEAP) for statistical analysis. We found that 93% of women had at least one DAP detected in their urine. Geomet­
ric means (GM) of speciﬁc gravity-corrected levels for urine dilution were 59 (95% CI 56–62) and 21 (95% CI 20– 
22) nmol/L for DMAP and DEAP, respectively. The following characteristics were signiﬁcantly associated with 
higher urinary concentrations of DMAP or DEAP: higher education, nulliparous, normal pre-pregnancy body 
mass index, non-smoker, not fasting at sampling, winter season at sampling, and early and late day collection 
times. Dietary items that were signiﬁcantly related with higher urinary concentrations included higher intake 
of citrus fruits, apple juice, sweet peppers, tomatoes, beans and dry peas, soy and rice beverages, whole grain 
bread, white wine and green and herbal teas. This study indicates that exposure to these compounds is quasi-
ubiquitous. The factors associated with greater DAP levels identiﬁed here could be useful to regulatory agencies 
for risk analysis and management. However, some exposure misclassiﬁcation might occur due to the single DAP 
measurement available, and to the presence of preformed DAPs in the environment. 
Crown Copyright © 2016 Published by Elsevier Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/by/4.0/). Keywords: 
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Dialkyl phosphates 
Organophosphate pesticide 
Pregnancy 1. Introduction 
Organophosphate (OP) pesticides are primarily used as insecticides, 
mostly in agriculture but also to ﬁght pests in residential and institu­
tional settings (EPA, 2013). They are less persistent than the organo­
chlorine pesticides that they replaced in the 1970s, but their acute 
toxicity in mammals is greater (Nauen et al., 2012). In turn, OPs are ntal and Occupational Health, 
uebec, Canada. 
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r Ltd. This is an open access article unow being replaced by other pesticides, such as pyrethroids (EPA, 
2011; van Balen et al., 2012); however, OPs are still commonly used 
today (Casida and Durkin, 2013). 
For non-occupationally exposed individuals, the main route of expo­
sure is ingestion of food, particularly contaminated fruits and vegetables 
(Oates et al., 2014). People living near farmlands can also be exposed by 
pesticides present in drinking water, air, and soil (Aggarwal et al., 2013; 
ATSDR, 2008). For occupationally-exposed individuals, the dermal route 
appears to be a signiﬁcant route of exposure (An et al., 2014; Kongtip et 
al., 2013). OP pesticides are readily absorbed by the oral route, but less 
so dermally (Garﬁtt et al., 2002; Nolan et al., 1984). They do not accu­
mulate appreciably in the body, and are rapidly metabolized and excret­
ed in urine (Barr and Angerer, 2006). Most OP pesticides undergo a 
similar metabolism, starting with bioactivation creating the toxic oxon nder the CC BY license (http://creativecommons.org/licenses/by/4.0/). 
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metabolites (Barr and Angerer, 2006). 
DAPs are non-speciﬁc urinary biomarkers of OP pesticides (i.e., each 
DAP can be generated from more than one OP pesticide); therefore, 
their measurement provides information about cumulative exposure 
to a large number of OP pesticides (Wessels et al., 2003). Furthermore, 
dimethyl OP pesticides produce only dimethyl alkyl phosphate 
(DMAP) metabolites, while diethyl OP pesticides produce only diethyl 
alkyl phosphate (DEAP) metabolites. Therefore, most studies group me­
tabolites into these two classes. The urinary concentration of DAPs is in­
dicative of exposure to OPs within hours or days of specimen sampling 
(Barr and Angerer, 2006). Results from the Canadian Health Measures 
Survey (CHMS) (2009–2011) indicate that 86% of the population had 
detectable levels of at least one DAP in urine (Health Canada, 2013). Fe­
males and children had higher levels than males and adults (Health 
Canada, 2013). It is important to note that preformed DAPs (residues 
of OP metabolites resulting from environmental degradation) can be 
found on food products after OP pesticide degradation and, thus, urinary 
DAPs are indicative of exposures to both OP pesticides and these 
preformed DAPs (CDC, 2009; EPA, 2013). Nonetheless, it is acknowl­
edged that the measurement of urinary DAPs is useful to identify and 
compare levels of OP pesticide exposure in various populations, and 
with varying exposure conditions (Krieger et al., 2012; Sudakin and 
Stone, 2011). 
While DAPs are metabolic products resulting in the detoxiﬁcation of 
OP's, the oxon metabolites of OP's are bioactivation products, which are 
more active and thus more toxic than the parent compound. The oxon­
metabolites of OP pesticides disrupt the nervous system by inhibiting 
acetylcholinesterase, the enzyme responsible for degrading acetylcho­
line in synapses, causing acetylcholine accumulation and resulting in 
excessive nerve stimulation (EPA, 2013). The mechanism of toxicity is 
less well understood for chronic low dose exposure. It could involve 
the parent compound instead of oxon-metabolite toxicity (Jameson et 
al., 2007) and mechanisms unrelated to acetylcholinesterase inhibition. 
Especially relevant for exposure to the developing fetus, multiple mech­
anisms have been reported to interfere with cellular processes that 
could directly affect brain morphogenesis, such as oxidative stress, 
growth factors, neurotransmitter and messenger systems (Lauder and 
Schambra, 1999; Slotkin, 2004; Slotkin and Seidler, 2007). 
Pregnant women may have exposures to environmental chemicals 
which differ from those of the general population, since they experience 
notable physiological and behavioral changes during pregnancy 
(Abduljalil et al., 2012; Moya et al., 2014). Fetuses can be exposed to 
OP pesticides, as these pesticides can cross the placental barrier and 
have been measured in amniotic ﬂuid samples (Bradman et al., 2003; 
Koutroulakis et al., 2014). Recent data indicate that the developing 
fetus might be particularly susceptible to OP toxicity. Exposure to OPs 
during pregnancy has been associated with shorter gestation duration, 
lower birth weight (Eskenazi et al., 2004; Rauch et al., 2012; Wang et 
al., 2012) and neurobehavioral impairment in young children 
(Bouchard et al., 2011; Gonzalez-Alzaga et al., 2013). 
Few biomonitoring studies on OP pesticides have been reported 
using large cohorts of pregnant women, in particular during the ﬁrst tri­
mester when the fetus undergoes organogenesis, a critical developmen­
tal period. The objectives of the present study were to report the levels 
measured in Canadian pregnant women and to examine the relation­
ship between urinary DAP levels in early pregnancy and various factors 
that may be potential sources of exposure or determinants of DAP 
levels. 
2. Materials and methods 
2.1. Study population 
The Maternal-Infant Research on Environmental Chemicals (MIREC) 
cohort study includes 2001 women recruited in early pregnancy (b14 weeks gestation) from obstetric and prenatal clinics in 10 cities 
in 6 Canadian provinces. Pregnant women were approached between 
2008 and 2011 and the participation rate was 39% from the 5108 eligible 
women (Arbuckle et al., 2013). Eligibility criteria included the ability to 
consent and to communicate in English or French, at least 18 years old, 
and planning to deliver at a participating study hospital. Exclusion 
criteria included having an adverse medical history: for either the 
mother (including major chronic disease, threatened abortion and 
illicit drug use) or the fetus (known major fetal abnormalities in­
cluding chromosomal anomalies). The MIREC Study was designed 
to provide biomonitoring data on chemical exposure in pregnant 
women living in Canada. Details on the cohort have been previously 
reported (Arbuckle et al., 2013). The research protocol was reviewed 
and approved by the  Health  Canada Research Ethics Board and 
each of the ethics committees at the participating hospitals and 
research centers. Each woman enrolled in the study signed an 
informed consent form. 
Of the 2001 women enrolled, 18 subsequently withdrew from 
the study. For the present study, we excluded women for whom 
urinary DAP or speciﬁc gravity measurements were not available 
(n = 50) and those with a multiple pregnancy (n = 49), leaving 
1884 participants. 2.2. Urine collection and analysis 
One spot urine sample was collected from each participant during 
the 1st trimester in 125 mL Nalgene® containers made of high-density 
polyethylene with polypropylene screw closure (Thermo-Fisher Scien­
tiﬁc Inc., Rochester NY, USA), aliquoted into 30 mL Nalgene® containers, 
frozen at −20 °C within 2 h of collection, and shipped on dry ice to the 
coordinating center in Montreal where they were stored at − 30 °C. 
Samples were then shipped in batches to the Centre de Toxicologie du 
Québec (CTQ) of the Institut National de Santé Publique du Québec 
(INSPQ) for determination of concentrations of DAP. Six DAP metabo­
lites were assessed in each urine sample: three DMAP molecules (di-
methyl phosphate (DMP), dimethyl thiophosphate (DMTP) and 
dimethyl dithiophosphate (DMDTP)) and three DEAP molecules 
(diethyl phosphate (DEP), diethyl thiophosphate (DETP) and diethyl 
dithiophosphate (DEDTP)). 
DAPs were analyzed by GC–MS/MS and the analytical procedure was 
previously published (Health Canada, 2010). First, extraction involved 
hydrolysis with β-glucuronidase enzyme, derivation with 
pentaﬂuorobenzyl bromide, and extraction of derivatized products 
using a mixture of dichloromethane:hexane (8:92). Then, analysis was 
done on an Agilent 6890 Network gas chromatograph (GC) (Agilent 
Technologies; Mississauga, Ontario, Canada) coupled to a Waters 
Quattro Micro GC mass spectrometer in tandem (MS/MS) (Waters; Mil­
ford, MA). The mass spectrometer was operated in Multiple Reaction 
Monitoring, using negative ion chemical ionization. The limits of detec­
tion (LOD) determination involved estimation of DAP concentrations 
yielding a signal-to-noise ratio (S/N) of 3, analysis of 10 replicates of a 
synthetic urine sample with DAP concentrations ranging from 4 to 10 
times the previously estimated concentrations, and calculation of 
LODs using the standard deviations multiplied by three. The intra-day 
precision (repeatability) and the inter-day precision (reproducibility) 
of the method were from 3.7 to 8.2% and 3.5 to 9.9%, respectively, 
depending on the DAP. Quality control was assured by two internal 
reference materials (a noncertiﬁed ClinChek urine from Germany, 
and a homemade reference prepared from a pool of urine from ex­
posed individuals), and the overall quality and accuracy of the 
method was monitored by the inter-laboratory program of the 
German External Quality Assessment Scheme (Erlangen, Germany). 
To assess urine dilution, speciﬁc gravity (SG) was measured in 
defrosted samples by a refractometer (UG-1, Atago / 3461, Atago 
U.S.A. Inc., Bellevue, WA). 
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Table 1 
Geometric means for urinary concentrations of DAP (nmol/L) corrected for speciﬁc gravity  
with respect to maternal and urine sampling characteristics in the MIREC Study (2008– 
2011). 
Maternal and urine sampling factors n (%) GM (nmol/L, 95% CI) 
ΣDMAP ΣDEAP 
Maternal characteristics 
Maternal age (years) p = 0.19 p = 0.39 
b 25 101 (5) 52 (41–66) 18 (41–66) 
25–29 405 (21) 59 (53–66) 21 (53–66) 
30–34 667 (35) 62 (58–68) 21 (58–68) 
≥35 711 (38) 56 (52–60) 21 (52–60) 
Education p = 0.02 p =  0.02 
High school 168 (9) 49 (41–59) 19 (16–21) 
College diploma 545 (29) 56 (51–61) 20 (18–21) 
University degree 1169 (62) 62 (58–66) 22 (21−23) 
Household income ($) p = 0.37 p = 0.04 
≤50,000 328 (18) 56 (49–63) 19 (17–21) 
50,001–100,000 752 (42) 62 (57–66) 22 (20−23) 
N100,000 716 (40) 58 (54–63) 21 (20−22) 
Birth place p = 0.53 p = 0.10 
Canada 1528 (81) 58 (55–61) 21 (20−21) 
Other 356 (19) 61 (54–68) 22 (20–25) 
Parity p b 0.001 p b 0.01 
0 853 (44) 68 (63–73) 22 (21–24) 
1 780 (40) 53 (49–57) 20 (19–21) 
N1 298 (15) 50 (44–56) 19 (17–21) 
Pre-pregnancy BMI (kg/m2)  p  =  0.01 p b 0.01 
b25 1123 (63) 62 (59–66) 22 (21–23) 
25–29 382 (22) 53 (47–59) 20 (18–22) 
≥30 265 (15) 54 (48–62) 19 (17–21) 
Smoking status p = 0.02 p b 0.01 
Never 1144 (61) 61 (58–65) 21 (20–22) 
Currenta 226 (12) 49 (42–57) 17 (15–20) 
Former 512 (27) 58 (52–63) 22 (20–23) 
Sampling characteristics 
Time of urine collection p = 0.001 p = 0.97 
06:00–09:00 27 (1) 65 (42–101) 23 (15–33) 
09:00–12:00 814 (43) 56 (52–60) 21 (19–22) 
12:00–15:00 637 (34) 55 (51–60) 22 (19–22) 
15:00–18:00 366 (19) 69 (62–78) 21 (19–23) 
18:00–24:00 38 (2) 87 (64–119) 20 (16–26) 
Time since last urination (min) p = 0.95 p = 0.17 
b 75 440 (23) 60 (54–66) 20 (18–22) 
75–119 359 (19) 58 (52–64) 22 (20–24) 
120–169 539 (29) 58 (53–64) 20 (18–22) 
≥ 170 453 (24) 59 (53–66) 22 (20–23) 
Fasting status p b 0.001 p = 0.18 
No 1822 (98) 59 (56–62) 21 (20–22) 
Yes 39 (2) 33 (23–46) 17 (13−23) 
Season of collection p = 0.05 p =  0.001 
Fall (Sept. 21–Dec. 20) 550 (29) 53 (48–58) 19 (18–20) 
Winter (Dec. 21–Mar. 19) 450 (24) 63 (57–70) 25 (23–27) 
Spring (Mar. 20–Jun. 20) 443 (24) 62 (56–68) 22 (20–24) 
Summer (Jun. 21–Sept. 20) 441 (23) 59 (53–65) 19 (17–20) 
a Includes women who quit smoking during current pregnancy. 2.3. Maternal sociodemographic and anthropometric characteristics and 
urine sampling conditions 
Information from questionnaires and medical charts, as well as bio­
logical specimens, was collected during each trimester and at delivery. 
In the present study, we used data obtained from questionnaires admin­
istered by trained research nurses and assistants during the 1st trimes­
ter study visit. This questionnaire collected information on the 
characteristics of the participants (i.e., maternal age and education, 
household income, birth place, parity, pre-pregnancy body mass index 
(BMI) and smoking status) and on the conditions of urine collection 
(i.e., time of collection, time since last void, fasting status of sampling, 
and season of collection). 
2.4. Maternal pesticide use, housing and diet 
Part of the 1st trimester questionnaire included questions relating to 
maternal pesticide use and housing. Questions were asked about 
whether the women had used or had been exposed to pesticides during 
the current pregnancy, at work or at home for: 1) lawn and garden in­
sects, 2) house plant insects, 3) pet ﬂeas, and 4) residential pests (cock­
roaches, rodents, ants, etc.). Housing factors included questions about 
pet ownership, type of building of current residence, and having any 
rooms in the home with wall-to-wall carpets. In our sample, b 1% of 
the data were missing for any given question. 
Extensive data were collected on dietary habits during pregnancy. 
During the 1st trimester, information was collected on both alcoholic 
and non-alcoholic beverage consumption since the beginning of preg­
nancy (number of glasses or cups consumed per day, week or month). 
During the second trimester visit between 16 and 21 weeks of pregnan­
cy, a one-month semi-quantitative food frequency questionnaire (FFQ) 
was administered including 46 food items listed in 6 subgroups (vege­
tables/fruits/meat, poultry, ﬁsh and alternatives/milk products/grain 
products/other foods). Only questions on grain products, fruits and veg­
etables were retained for the current analysis and included frequency of 
consumption (per day, week or month) as well as the serving size. As 
practiced by Health Canada, when small or large portions were report­
ed, we applied a reduction or an inﬂation factor of 33% of the normal 
size, respectively. For each food and drink item, the consumption was 
categorized into three groups as evenly distributed as possible; howev­
er, for some drink items, only two categories were created as few 
women reported consuming any. 
2.5. Statistical analysis 
The analyses of factors associated with DAP levels in maternal urine 
were conducted using urinary concentrations which were corrected for 
speciﬁc gravity (SG) to account for urine dilution. Concentrations were 
corrected for SG using the following adapted formula (Just et al., 2010): 
Pc = Pi[(SGm − 1/SGi − 1)], where Pc is the SG-corrected metabolite 
concentration, Pi is the observed metabolite concentration, SGi is the 
SG of the ith urine sample and SGm is the median SG for the cohort. 
To calculate ΣDMAP and ΣDEAP levels, we converted mass concen­
trations in urine (μg/L) into molar concentrations (nmol/L) using the 
following molecular masses in g/mol: 126.05 (DMP), 142.11 (DMTP), 
158.18 (DMDTP), 154.10 (DEP), 170.17 (DETP), and 186.24 (DEDTP). 
The robust regression on order statistics (ROS) semiparametric method 
was used to impute data below the LOD (Helsel, 2012) with R software. 
ROS combines parametric and nonparametric methods and is recom­
mended for approximatively normal or lognormal distributions. Con­
centrations under the LOD were imputed for each of the 6 DAPs. 
Molar concentrations were log 10 transformed for the statistical analy­
ses because the distributions were lognormal. 
Univariate models were performed to identify the relationship be­
tween log 10 ΣDMAP and ΣDEAP levels and each participant's charac­
teristics using analysis of variance (ANOVA). Beforehand, Lilliefors test was used to verify the normality of residual distributions for each factor 
category and Levene's test was used to test homogeneity of variances 
between categories of each factor. A p-value b 0.05 was used for statis­
tical signiﬁcance. Statistical analysis was performed using SPSS (version 
22) and R (R Development Core Team). 
3. Results 
3.1. Cohort proﬁle and urinary DAP levels 
The sociodemographic characteristics of the 1884 participants in­
cluded in the present study are outlined in Table 1. Most women in 
this cohort were highly educated (62% had a university degree), were 
non-smokers (61% never smoked), and 73% were 30 years of age and 
older (mean 32.6 ± 5.1, range 18–48 years). The median gestational 
age at the time of women's recruitment into the study, which is when 
urine was collected for DAP measurement, was 12.0 weeks (range 
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Table 2 
Descriptive statistics on urinary concentrations of DAP uncorrected and corrected for speciﬁc gravity in women from the MIREC Study (n = 1884; 2008–2011). 
Metabolites LOD % Uncorrected DAP concentrations (nmol/L) SG-corrected DAP concentrations (nmol/L) 
nmol/L μg/L bLOD GM (95% CI) Median (95% CI) 95th perc. Max. GM (95% CI) Median (95% CI) 95th perc. Max. 
DMP 
DMTP 
DMDTP 
DEP 
DETP 
DEDTP 
ΣDMAPb 
ΣDEAPc 
ΣDAPd 
7.93 
4.22 
1.90 
6.49 
3.53 
1.61 
1.90 
1.61 
1.61 
1.00 
0.60 
0.30 
1.00 
0.60 
0.30 
0.30 
0.30 
0.30 
21 
20 
49 
23 
47 
98 
13 
20 
7 
23 (22–24) 
20 (19–22) 
2 (2–2) 
14 (14–15) 
3 (3–3) 
NCa 
52 (49–55) 
19 (18–19) 
78 (74–82) 
23 (21–25) 
21 (19–24) 
2 (2–2) 
14 (14–15) 
3 (2–3) 
NCa 
52 (49–56) 
18 (17–19) 
78 (74–83) 
167 
239 
38 
84 
25 
NCa 
440 
113 
538 
1507 
690 
518 
22,064 
294 
35 
1611 
22,076 
22,516 
26 (25–27) 
23 (21–24) 
2 (2–2) 
16 (15–17) 
3 (3–3) 
NCa 
59 (56–62) 
21 (20–22) 
88 (84–92) 
26 (25–28) 
24 (22–26) 
2 (2–3) 
16 (15–17) 
4 (3–4) 
NCa 
60 (56–64) 
21 (20–22) 
86 (82–91) 
134 
210 
33 
66 
21 
NCa 
346 
86 
407 
852 
903 
250 
13,658 
224 
22 
1310 
13,666 
13,939 
a NC: not calculated because N50% of values were below the LOD. 
b ΣDMAP = DMP + DMTP + DMDTP. 
c ΣDEAP = DEP + DETP + DEDTP. 
d ΣDAP = ΣDMAP + ΣDEAP. 
 
 
Table 3 
Geometric means for urinary concentrations of DAP (nmol/L) corrected for speciﬁc gravity  
with respect to pesticide use and dwelling characteristics since the beginning of current 
pregnancy for women from the MIREC Study (2008–2011). 
Pesticide use and dwelling characteristics n (%) GM (nmol/L, 95% CI) 
ΣDMAP ΣDEAP 
Pesticide use for: 
Lawn and garden insects p = 0.51 p = 0.56 
No 1812 (97) 59 (56–62) 21 (20–22) 
Yes 60 (3) 64 (50–83) 20 (16–24) 
House plant insects p = 0.28 p = 0.74 
No 1844 (98) 59 (56–62) 21 (20–22) 
Yes 34 (2) 48 (33–70) 22 (17–28) 
Pet ﬂeas p = 0.27 p = 0.76 
No 1750 (93) 59 (56–62) 21 (20–22) 
Yes 125 (7) 53 (44–64) 20 (17–24) 
Residential pestsa p = 0.06 p = 0.67 
No 1723 (92) 58 (55–61) 21 (20–22) 
Yes 155 (8) 69 (58–82) 21 (19–25) 
Owning a dog or a cat p = 0.10 p = 0.66 
No 906 (48) 61 (57–66) 21 (20–22) 
Yes 975 (52) 56 (53–60) 21 (20–22) 
Type of residence p = 0.90 p = 0.88 
Semi or fully-detached house 1513 (80) 59 (56–62) 21 (20–22) 
Apartment building 367 (20) 58 (52–66) 21 (19–23) 
Wall-to-wall carpets in any room p = 0.40 p = 0.62 
No 853 (45) 60 (56–65) 21 (20–22) 
Yes 1027 (55) 58 (54–61) 21 (20–22) 
a Cockroaches, rodents, ants, etc. 2.7–15.9 weeks). Further details on the MIREC study population are re­
ported elsewhere (Arbuckle et al., 2013). 
Descriptive statistics for DAP levels are shown in Table 2, and results 
expressed as μg/L are shown in the Supplemental Material. Among 
women participating, 93% had at least one DAP metabolite detected in 
urine among the six DAPs analyzed. The three most prevalent DAPs in 
maternal urine were DMP, DMTP and DEP, with frequencies of detection 
of 79%, 80% and 77%, respectively. DMDTP, DETP and DEDTP had detec­
tion frequencies of 51%, 53% and 2%, respectively. For the DMAP metab­
olites, the geometric mean (GM) SG-corrected DMP concentration 
(26 nmol/L) was similar to that of DMTP (23 nmol/L), while the GM 
SG-corrected DMDTP concentration was much lower (2 nmol/L). The 
GM for the sum of these three metabolites (ΣDMAP) was 59 nmol/L. 
For the DEAP metabolites, the GM SG-corrected concentration of DEP 
(16 nmol/L) was higher than that of DETP (3 nmol/L); it was not calcu­
lated for DEDTP because of the low detection frequency (2%). The geo­
metric mean of the sum of these three metabolites (ΣDEAP) was 
21 nmol/L. 
3.2. Relation between urinary DAP concentrations, maternal characteristics 
and sample collection conditions 
When maternal characteristics (including age, education, income, 
birth place, parity, pre-pregnancy BMI and smoking status) were exam­
ined, higher urinary concentrations of ΣDMAP and ΣDEAP (Table 1) 
were associated with several factors, including education level, parity, 
pre-pregnancy BMI and smoking status. DAP concentrations increased 
with education level for both ΣDMAP (GMHighSchool = 49  and
GMUniversity = 62 nmol/L) and ΣDEAP (GMHighSchool = 19  and
GMUniversity = 22 nmol/L). DAP concentrations decreased with parity 
for both ΣDMAP (GM0 = 68 and  GMN1 = 50 nmol/L) and ΣDEAP 
(GM0 =22  and  GMN1 = 19 nmol/L), and decreased with pre-pregnancy 
BMI for both ΣDMAP (GMb25 =62  and  GM≥30 = 54 nmol/L) and ΣDEAP 
(GMb25 =22  and  GM≥30 = 19 nmol/L). In addition, women who never 
smoked had signiﬁcantly higher DAP concentrations than current 
smokers for both ΣDMAP (GMNever = 61 and GMCurrent = 49 nmol/L) 
and ΣDEAP (GMNever = 21  and  GMCurrent = 17 nmol/L); former 
smokers had similar ΣDMAP and ΣDEAP concentrations to women 
who never smoked. Finally, ΣDEAP concentrations were signiﬁcantly 
lower in the lower income group (GM≤50.000 = 19  and  GM50– 
100.000 = 22 nmol/L). No signiﬁcant differences were observed in 
ΣDMAP and ΣDEAP concentrations with respect to maternal age and 
maternal birth place. 
With respect to urine sampling characteristics (Table 1), DAP con­
centrations were signiﬁcantly different according to the season at 
urine collection, with levels higher in the winter than the fall for both 
ΣDMAP (GMWinter = 63 and  GMFall = 53 nmol/L) and ΣDEAP 
(GMWinter = 25  and  GMFall = 19 nmol/L). ΣDMAP concentrations dif­
fered signiﬁcantly by time of the day at urine collection, with levels lower in the middle of the day than earlier or later in the day (e.g., 
GM12:00–15.00 =55 and  GM15:00–18.00 = 69 nmol/L). ΣDMAP concentra­
tions were signiﬁcantly lower in samples collected from fasting women 
(GMYes = 33 and  GMNo = 59 nmol/L), but there were very few fasting 
participants (2%). No signiﬁcant difference was observed in ΣDMAP and 
ΣDEAP concentrations with respect to time since last urination. 3.3. Relation between urinary DAP concentrations and characteristics relat­
ed to pesticide use and dwelling characteristics 
Few women reported using or having been exposed to pesticides 
since they were pregnant (2–8%, depending on the type of pesticide 
use) (Table 3). Although not statistically signiﬁcant, there was a trend 
for higher ΣDMAP concentrations in women who reported pesticide 
use for residential pests (e.g., cockroaches, rodents, ants, etc.) 
(GMYes = 69 and GMNo = 58 nmol/L). No difference was observed in 
ΣDMAP concentrations with respect to type of housing, pet ownership, 
or wall-to-wall carpet in the house. Finally, ΣDEAP concentrations were 
not associated with pesticide use or dwelling characteristics. 
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Table 5 
Geometric means for urinary concentrations of DAP (nmol/L) corrected for speciﬁc gravity  
with respect to grain products consumption, of women from the MIREC Study (2008– 
2011). 
Grain products consumptiona n (%) GM (nmol/L, 95% CI) 
ΣDMAP ΣDEAP 
Soy and rice beverages p = 0.006 p = 0.11 
Low 1475 (85) 58 (55–61) 21 (20–22) 
High 270 (15) 70 (62–79) 23 (21–25) 
Cold cereal p = 0.05 p = 0.06 
Low 581 (33) 55 (50–60) 20 (18–21) 
Medium 531 (30) 59 (54–64) 22 (20–23) 
High 633 (36) 64 (59–70) 22 (20–23) 
Hot cereal p = 0.71 p = 0.95 
Low 1033 (59) 60 (56–64) 21 (20–22) 
Medium 196 (11) 56 (48–65) 21 (19–24) 
High 516 (30) 60 (55–66) 21 (19–23) 
White bread p = 0.03 p = 0.15 
Low 590 (34) 65 (59–70) 21 (20–23) 
Medium 572 (33) 59 (54–64) 22 (20–24) 
High 583 (33) 55 (50–60) 20 (19–21) 
Whole grain bread p = 0.02 p = 0.15 
Low 958 (55) 55 (51–59) 20 (19–22) 
High 787 (45) 65 (61–70) 22 (21–23) 
Pasta p = 0.45 p = 0.03 3.4. Relation between urinary DAP concentrations and food, drinks, and 
alcohol 
The consumption of several vegetables and fruits was associated 
with signiﬁcant differences in urinary DAP concentrations (Table 4). 
DAP concentrations increased signiﬁcantly with citrus fruit consump­
tion for both ΣDMAP (GMLow = 53  and  GMHigh = 71 nmol/L) and 
ΣDEAP (GMLow = 19  and  GMHigh = 23 nmol/L). The concentrations 
also increased signiﬁcantly with apple juice consumption for both 
ΣDMAP (GMLow = 52 and GMHigh = 70 nmol/L) and ΣDEAP 
(GMLow = 19  and  GMHigh = 24 nmol/L). ΣDMAP concentrations in­
creased signiﬁcantly with higher consumption of sweet peppers 
(GMLow = 50 and GMHigh = 69 nmol/L), tomatoes (GMLow = 54 and 
GMHigh = 67 nmol/L), beans and dry peas (GMLow = 54  and  GMHigh = 
65 nmol/L). Although not statistically signiﬁcant, there was a trend for 
higher ΣDMAP concentrations with broccoli consumption (GMLow = 
55 and GMHigh = 62 nmol/L), and for higher ΣDEAP concentrations 
with raw spinach consumption (GMLow = 20 and  GMHigh = 23  nmol/  
L). There was no difference in ΣDMAP and ΣDEAP concentrations with 
respect to tomato or vegetable juice, potatoes, or grape juice. 
The results for grain products are shown in Table 5. ΣDMAP concen­
trations increased signiﬁcantly with increased consumption of soy and Table 4 
Geometric means for urinary concentrations of DAP (nmol/L) corrected for speciﬁc gravity  
with respect to vegetable and fruit consumption, of women from the MIREC Study (2008– 
2011). 
Vegetable and fruit consumption n (%) GM (nmol/L, 95% CI) 
ΣDMAP ΣDEAP 
Broccolia p = 0.08 p = 0.34 
Low 667 (38) 55 (51–60) 20 (19–22) 
Medium 549 (31) 62 (55–68) 22 (20–24) 
High 529 (30) 62 (57–68) 21 (20–23) 
Raw spinacha p = 0.12 p = 0.07 
Low 925 (53) 57 (53–61) 20 (19–22) 
Medium 316 (18) 65 (58–73) 20 (19–23) 
High 504 (29) 61 (56–67) 23 (21–24) 
Sweet peppersa p b 0.001 p = 0.37 
Low 587 (34) 50 (46–55) 20 (19–22) 
Medium 653 (37) 61 (56–66) 21 (20–22) 
High 505 (29) 69 (64–76) 22 (20–24) 
Tomatoesa p =  0.003 p = 0.15 
Low 682 (39) 54 (49–59) 21 (19–22) 
Medium 633 (36) 61 (56–66) 20 (19–22) 
High 430 (25) 67 (61–74) 23 (21–24) 
Tomato or vegetable juicea p = 0.83 p = 0.66 
Low 1179 (68) 59 (55–63) 21 (20–22) 
Medium 283 (16) 59 (52–67) 22 (20–24) 
High 283 (16) 62 (55–70) 21 (29–23) 
Potatoesa p = 0.92 p = 0.29 
Low 633 (36) 59 (54–64) 22 (20–24) 
Medium 555 (32) 60 (55–66) 20 (19–22) 
High 557 (32) 60 (55–65) 21 (19–22) 
Beans and dry peasa p =  0.02 p = 0.13 
Low 658 (38) 54 (50–59) 20 (19–22) 
Medium 531 (30) 61 (56–66) 21 (19–22) 
High 533 (31) 65 (59–70) 22 (21–24) 
Citrus fruitsa p b 0.001 p b 0.001 
Low 688 (39) 53 (49–58) 19 (18–21) 
Medium 524 (30) 58 (53–63) 21 (20–23) 
High 533 (31) 71 (65–77) 23 (22–25) 
Apple Juiceb p b 0.001 p b 0.001 
Low 866 (46) 52 (48–55) 19 (18–20) 
Medium 550 (29) 62 (56–68) 21 (19–22) 
High 463 (25) 70 (63–77) 24 (23–26) 
Grape juice or cocktailb p = 0.53 p = 0.54 
Low 1393 (74) 58 (55–61) 21 (20–22) 
Medium 258 (14) 60 (53–69) 21 (19–24) 
High 228 (12) 63 (55–71) 22 (20–25) 
a From FFQ administered during 2nd trimester. 
b From questionnaire administered during 1st trimester. 
Low 641 (37) 60 (55–65) 22 (20–23) 
Medium 567 (32) 62 (56–67) 22 (21–24) 
High 537 (31) 57 (52–62) 19 (18–21) 
Crackers p = 0.95 p = 0.68 
Low 605 (35) 59 (54–64) 21 (19–22) 
Medium 660 (38) 60 (55–65) 21 (19–22) 
High 480 (28) 59 (54–65) 22 (20–23) 
Cookies p = 0.23 p = 0.60 
Low 705 (61) 62 (58–68) 21 (19–22) 
Medium 459 (39) 58 (53–64) 21 (19–22) 
High 581 (50) 57 (52–62) 22 (20–23) 
Cake p = 0.04 p = 0.74 
Low 575 (33) 57 (52–62) 21 (19–22) 
Medium 583 (33) 65 (60–71) 21 (20–23) 
High 587 (34) 57 (52–62) 21 (20–23) 
Snack bars made of cereals p = 0.10 p = 0.20 
Low 916 (52) 57 (53–61) 22 (20–23) 
Medium 353 (20) 59 (53–65) 20 (19–21) 
High 476 (27) 65 (59–71) 21 (19–23) 
a From FFQ administered during 2nd trimester. rice beverage (GMLow = 58  and  GMHigh = 70 nmol/L) and whole 
grain bread (GMLow = 55 and GMHigh = 65 nmol/L), whereas it de­
creased signiﬁcantly with increased white bread consumption (includ­
ing rolls, buns, bagels, pita and tortillas) (GMLow = 65 and GMHigh = 
55 nmol/L). ΣDEAP concentrations were signiﬁcantly lower with higher 
pasta consumption (GMLow =22 and  GMHigh = 19 nmol/L). There was 
a trend for higher levels with higher cold cereal consumption for both 
ΣDMAP (GMLow = 55  and  GMHigh = 64 nmol/L) and ΣDEAP 
(GMLow = 20 and GMHigh = 22 nmol/L), and with consumption of 
snack bars made of cereals for ΣDMAP (GMLow = 57  and  GMHigh = 
65 nmol/L). ΣDMAP concentrations differed signiﬁcantly with cake con­
sumption (including mufﬁns, pies, pastries and doughnuts), but there 
was no clear relation with the level of intake. No difference was ob­
served in ΣDMAP and ΣDEAP concentrations with respect to various 
consumption patterns for hot cereal, crackers and cookies. 
Urinary DAP concentrations increased signiﬁcantly with increased 
white wine consumption (Table 6) for both ΣDMAP (GMLow = 57  and  
GMHigh = 66 nmol/L) and ΣDEAP (GMLow = 20  and  GMHigh = 
23 nmol/L). ΣDMAP concentrations increased signiﬁcantly with in­
creased green tea consumption (GMLow = 57 and  GMHigh = 65  nmol/  
L), and there was a trend for higher ΣDMAP concentrations with in­
creased consumption of red wine (GMLow = 57  and  GMHigh = 
64 nmol/L) and beer (GMLow = 57 and GMHigh = 65 nmol/L). ΣDEAP 
concentrations increased signiﬁcantly with increased herbal tea con­
sumption (GMLow = 20  and  GMHigh = 22 nmol/L), whereas they 
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Table 6 
Geometric means for urinary concentrations of DAP (nmol/L) corrected for speciﬁc gravity  
with respect to drinks consumption of pregnant women from the MIREC Study (2008– 
2011). 
Drinks consumptiona n (%) GM (nmol/L, 95% CI) 
ΣDMAP ΣDEAP 
Regular and decaffeinated coffee p = 0.16 p = 0.36 
Low 875 (47) 61 (56–65) 21 (20–23) 
Medium 422 (22) 61 (55–67) 21 (19–23) 
High 579 (31) 55 (50–59) 20 (19–21) 
Regular tea p = 0.25 p = 0.34 
Low 1112 (59) 60 (56–64) 21 (20–22) 
High 767 (41) 57 (52–61) 20 (19–22) 
Green tea p = 0.02 p = 0.82 
Low 1451 (77) 57 (54–60) 21 (20–22) 
High 429 (23) 66 (59–72) 21 (19–23) 
Herbal tea p = 0.14 p = 0.04 
Low 1171 (62) 57 (54–61) 20 (19–21) 
High 707 (38) 62 (57–67) 22 (21–23) 
White wine p = 0.03 p =  0.04 
Low 1577 (84) 57 (54–60) 20 (20–21) 
High 302 (16) 66 (59–75) 23 (21–25) 
Red wine p = 0.05 p = 0.57 
Low 1432 (76) 57 (54–60) 21 (20–22) 
High 445 (24) 64 (58–71) 21 (20–23) 
Beer p = 0.07 p b 0.001 
Low 1563 (83) 57 (55–61) 21 (20–22) 
High 315 (17) 65 (57–74) 19 (18–22) 
a From questionnaire administered during 1st trimester. decreased signiﬁcantly with increased beer consumption (GMLow = 21  
and GMHigh = 19 nmol/L). No difference in urinary DAP concentrations 
were observed with various coffee and regular tea consumption 
patterns. 4. Discussion 
In this study, we report urinary DAP concentrations, which are me­
tabolites of OP pesticides, measured early in pregnancy among 
women from the MIREC cohort. We found that 93% of women had at 
least one DAP detected in their urine, similar to the general population 
living in Canada at 91% (Ye et al., 2015). Looking individually at the 
three most often detected DAPs (DMP, DMTP, DEP), levels in this 
study were similar to nonpregnant women living in Canada for DMP 
(GMMIREC = 23 and  GMCHMS = 21 nmol/L) and DEP (GMMIREC = 
GMCHMS = 14 nmol/L), but slightly higher for DMTP (GMMIREC = 20  
and GMCHMS = 13 nmol/L) (Health Canada, 2013). In the present 
study, levels were lower than those found in pregnant women from 
an agricultural community in California (Bradman et al., 2005) for  
ΣDMAP (GMMIREC = 52  and  GMCHAMACOS = 83 nmol/L), and similar 
for ΣDEAP (GMMIREC =19  and  GMCHAMACOS = 17 nmol/L). While levels 
in pregnant Canadian women were slightly higher than those previous­
ly reported in pregnant women from the general population living in 
USA for DMTP (GMMIREC = 20 and  GMNHANES = 17 nmol/L) 
(Woodruff et al., 2011), levels were lower than those noted in pregnant 
women in China for DMP (GM = 143 nmol/L), DMTP (GM = 60 nmol/ 
L) and DEP (GM = 46 nmol/L) (Zhang et al., 2014). 
Eighteen OP pesticides were registered in Canada during the time of 
the present study (2009–2011) (Health Canada, 2013). This included 
eight dimethyl OPs (azinphos-methyl, dimethoate, malathion, and 
phosmet, dichlorvos, naled, tetrachlorvinphos and trichlorfon) produc­
ing DMAP metabolites, six diethyl OPs (chlorpyrifos, coumaphos, diazi­
non, phorate, phosalone and terbufos) producing DEAP metabolites, 
and four OPs not producing DAP metabolites (acephate, bensulide, 
methamidophos and propetamphos). Among insecticides, chlorpyrifos 
was the third most sold insecticide active ingredient in 2012 (between 
100,000 and 500,000 kg of active ingredient) after mineral oil and hydrogen peroxide. Among OP pesticides most sold in 2012, chlorpyri­
fos was followed by dimethoate, malathion and diazinon (Health 
Canada, 2012). These pesticides are widely used in agricultural settings. 
In Canada, a large fraction of certain fruits and vegetables have de­
tectable pesticide residues (CFIA, Canadian Food Inspection Agency, 
2008–2012 reports). For instance, N33% of samples for the following 
foods had multiple pesticides detected: orange, strawberry, celery, 
pea, bean, spinach, grape, apricot, apple, cucumber, lettuce leaf and po­
tato. Some of these produce were associated with greater urinary DAP 
levels in the present study (e.g. citrus fruits, apple juice, sweet peppers, 
beans and peas). Based on monitoring data for pesticide residues in 
fresh fruit and vegetables available for consumption in Canada, chlor­
pyrifos, phosmet, methamidophos, malathion, profenofos and acephate 
were among the pesticides implicated in the pesticide residue violations 
observed between 2008 and 2012 (e.g., 0.26% and 0.14% of samples test­
ed for chlorpyrifos and for phosmet had residues greater than the max­
imum residue limit). Pesticide residue violations are more common in 
imported produce than in produce from Canada (0.9–2% versus 0.2– 
0.8%, respectively). In the present study, higher DMAP concentrations 
were measured in samples collected during winter, a season when 
Canadians rely greatly on imported produce. In addition, lower DMAP 
concentrations were measured when women were fasting (8–12 h be­
fore sampling, water allowed), supporting the substantial amount of 
data already showing that diet is an important source of OP pesticides 
exposure. 
In MIREC, DMAPs were more frequently detected than DEAPs, and 
they were present in higher concentrations. This is consistent with ﬁnd­
ings in other studies (Eskenazi et al., 2007; Health Canada, 2013; Ye 
et al., 2008; Zhang et al., 2014). This may indicate that levels of exposure 
are greater in the population for dimethyl OP pesticides such as malathi­
on and dimethoate, the dimethyl OP pesticides most often used in 
Canada. Also, the longer environmental half-lives of DMAP might con­
tribute to this ﬁnding (Ye et al., 2008). 
In the present study, women had higher DAP urinary concentrations 
if they were more educated, had a higher income, did not smoke and 
had a pre-pregnancy BMI below 25 kg/m2. These characteristics might 
very well be associated with a greater awareness on the importance of 
good nutrition, which includes higher consumption of fruits and vegeta­
bles. A higher income also allows individuals to make this dietary choice 
(Kamphuis et al., 2006; Raine, 2005). 
Pesticide use was seldom reported by MIREC women. If reported, it 
was most frequently for pet ﬂeas and residential pests; however, the 
reporting time period for this question was only within the few weeks 
after the beginning of their pregnancy. Although not statistically signif­
icant, there was a trend for higher ΣDMAP levels in women reporting 
pesticide use for residential pests. This was unexpected since no di-
methyl OP pesticide is registered for indoor residential use in Canada, 
but they are for lawn and garden (e.g., malathion for ﬂies and garden in­
sects, including mosquitoes and spiders). Instead, it was expected 
ΣDEAP levels to be higher in women reporting pesticide use for residen­
tial pests, since diethyl OP pesticide are registered for indoor residential 
use in Canada (e.g., chlorpyrifos for ants). In contrast to the ﬁndings of a 
previous study (Valcke et al., 2006), we observed no difference in DAP 
levels between women living in a house with a pet or not. 
Our results showed that several fruits and vegetables consumed 
were associated with higher DAP levels. For instance, ΣDMAP levels 
were higher in women reporting higher intake of sweet peppers (38% 
higher than the lowest intake group), tomatoes (24%), beans and dry 
peas (20%) and citrus fruits (34%). This observation is consistent with 
other population-based studies where higher exposures to OP pesti­
cides were related to fruit and vegetable consumption (Berman et al., 
2013; McKelvey et al., 2013; Ye et al., 2015). Higher ΣDMAP levels 
were also observed with soy and rice beverages (21%) and whole 
grain bread (18%) consumption. On the other hand, higher intakes of 
pasta and white bread were associated with lower DAP levels. A possible 
explanation is that individuals who eat white bread presumably eat less 
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being associated with higher DAP exposure. Ye and collaborators 
(2015) reported no relationship between ΣDMAP levels and consump­
tion of grain and grain-based products. In their analysis, grain and grain-
based products were studied as a whole group, whereas in the present 
study we analyzed each of these products separately. An increase of 
DAP levels was also observed with increased white wine (16% with 
ΣDMAP and 15% with ΣDEAP), green tea (16% with ΣDMAP) and herbal 
tea (10% with ΣDEAP) consumption. Colapinto et al. (2015) found no as­
sociation with tea consumption when looking at individual urinary DAP 
concentrations. However, pesticide residues are often found in tea, with 
41% of the samples presenting residues concentrations above the max­
imum limit in a recent survey (CFIA, Canadian Food Inspection Agency, 
2009–2010a, b). 
A strength of the MIREC study is the large sample size, with partici­
pants drawn from a diverse pregnant population across Canada en­
abling the more accurate estimation of exposure ranges. This is one of 
the largest sample sizes reported for measurements of DAPs during 
pregnancy, internationally. Another strength is the adjustment for 
urine dilution with SG. This method is more appropriate to assess expo­
sure during pregnancy than the common approach using creatinine. In­
deed, it has been shown that creatinine urinary levels are affected by 
various factors such as age, muscular mass and pregnancy (Boeniger 
et al., 1993). 
Several factors must be considered when interpreting our results. As 
DAPs are non-speciﬁc metabolites, the identities of the speciﬁc OP par­
ent pesticide(s) remains unknown. Also, only one spot urine sample 
was collected from each participant during the 1st trimester (the labo­
ratory costs preclude collection of multiple samples per woman in 
most large studies). Because most OP pesticides have short biological 
half-lives (WHO, World Health Organization, 1986), urinary DAP con­
centrations reﬂect recent exposure. Serial urine specimens in pregnant 
women in the Netherlands showed moderate to low reliability, with 
an intraclass correlation coefﬁcient of 0.3 for total DAPs (values near 
one indicating high reliability) (Spaan et al., 2015). The collection of sev­
eral urine samples per woman would have provided a more robust esti­
mation of long-term exposure to these compounds. Furthermore, the 
population is also exposed to DAPs present in the environment 
(preformed DAPs), therefore urinary DAP levels might be interpreted 
as an indication of the general level of a population exposure to OP pes­
ticides or to preformed DAPs. The relative contribution of preformed 
DAP to total maternal urinary levels of DAP could not be ascertained 
in this investigation. Some of the data on the diet were collected 
a few months after urine sampling, possibly impacting the results 
if dietary changes occurred. It is possible that some ﬁndings oc­
curred by chance since we conducted multiple tests of statistical 
association. Finally, we should be cautious when generalizing the 
factors associated with increased cumulative exposure to OP's in 
pregnant women in Canada since the cohort of women in the pres­
ent study was healthier, more educated, smoked less and was older 
on average than pregnant women in the general population in 
Canada (Arbuckle et al., 2013). 
In conclusion, the present study identiﬁed the following characteris­
tics that were signiﬁcantly associated with higher urinary concentra­
tions of DMAP or DEAP: higher education, nulliparous, normal pre-
pregnancy body mass index, non-smoker, fasting, winter season at sam­
pling and early and late day collection times. Some of the maternal char­
acteristics associated with higher DAP urinary concentrations might be 
associated with a greater awareness of the importance of good nutri­
tion, such consuming fresh produce, which is also associated with great­
er pesticide exposure. Dietary items signiﬁcantly related with higher 
concentrations included higher intake of citrus fruits, apple juice, 
sweet peppers, tomatoes, beans and dry peas, soy and rice beverages, 
whole grain bread, white wine, green and herbal tea. The factors associ­
ated with greater DAP levels identiﬁed here could be useful to regulato­
ry agencies for risk analysis and management. Acknowledgments 
The authors thank Dr. Youssef Oulhote for providing help with the 
statistical analyses. MIREC participants, coordinating and recruitment 
site staff and the site investigators are gratefully acknowledged. The 
MIREC study was funded by Health Canada's Chemicals Management 
Plan, the Canadian Institute of Health Research (grant # MOP — 
81285) and the Ontario Ministry of the Environment. K Sokoloff was 
supported by a CIHR-Quebec Training Network in Perinatal Research 
(QTNPR) Doctoral scholarship. References 
Abduljalil, K., Furness, P., Johnson, T.N., Rostami-Hodjegan, A., Soltani, H., 2012. Anatomical, 
physiological and metabolic changes with gestational age during normal pregnancy: 
a database for parameters required in physiologically based pharmacokinetic 
modelling. Clin. Pharmacokinet. 51 (6), 365–396. http://dx.doi.org/10.2165/ 
11597440-000000000-00000. 
Aggarwal, V., Deng, X., Tuli, A., Goh, K.S., 2013. Diazinon-chemistry and environmental 
fate: a California perspective. Rev. Environ. Contam. Toxicol. 223, 107–140. http:// 
dx.doi.org/10.1007/978-1-4614-5577-6_5. 
An, X., Ji, X., Wu, M., Hu, X., Yu, R., Zhao, X., Cai, L., 2014. Risk assessment of applicators to 
chlorpyrifos through dermal contact and inhalation at different maize plant heights 
in China. J. Agric. Food Chem. 62 (29), 7072–7077. http://dx.doi.org/10.1021/jf501027s. 
Arbuckle, T.E., Fraser, W.D., Fisher, M., Davis, K., Liang, C.L., Lupien, N., Bastien, S., Velez, 
M.P., von Dadelszen, P., Hemmings, D.G., Wang, J., Helewa, M., Taback, S., Sermer, 
M., Foster, W., et al., 2013. Cohort proﬁle: the maternal-infant research on environ­
mental chemicals research platform. Paediatr. Perinat. Epidemiol. 27 (4), 415–425. 
http://dx.doi.org/10.1111/ppe.12061. 
ATSDR (Agency for Toxic Substances and Disease Registry), 2008. Toxicological Proﬁle for 
Diazinon. US Dept. of Health and Human Services, Public Health Service, Agency for 
Toxic Substances and Disease Registry, Atlanta, GA (Retrieved from) http://purl. 
fdlp.gov/GPO/gpo30736 (Accessed October 27, 2015). 
Barr, D.B., Angerer, J., 2006. Potential uses of biomonitoring data: a case study using the 
organophosphorus pesticides chlorpyrifos and malathion. Environ. Health Perspect. 
114 (11), 1763–1769. 
Berman, T., Goldsmith, R., Goen, T., Spungen, J., Novack, L., Levine, H., Amitai, Y., Shohat, T., 
Grotto, I., 2013. Urinary concentrations of environmental contaminants and 
phytoestrogens in adults in Israel. Environ. Int. 59, 478–484. http://dx.doi.org/10. 
1016/j.envint.2013.07.012. 
Boeniger, M.F., Lowry, L.K., Rosenberg, J., 1993. Interpretation of urine results used to as­
sess chemical exposure with emphasis on creatinine adjustments: a review. Am. Ind. 
Hyg. Assoc. J. 54 (10), 615–627. http://dx.doi.org/10.1080/15298669391355134. 
Bouchard, M.F., Chevrier, J., Harley, K.G., Kogut, K., Vedar, M., Calderon, N., Trujillo, C., 
Johnson, C., Bradman, A., Barr, D.B., Eskenazi, B., 2011. Prenatal exposure to organo­
phosphate pesticides and IQ in 7-year-old children. Environ. Health Perspect. 119 
(8), 1189–1195. http://dx.doi.org/10.1289/ehp.1003185. 
Bradman, A., Barr, D.B., Claus Henn, B.G., Drumheller, T., Curry, C., Eskenazi, B., 2003. Measure­
ment of pesticides and other toxicants in amniotic ﬂuid as a potential biomarker of 
prenatal exposure: a validation study. Environ. Health Perspect. 111 (14), 1779–1782. 
Bradman, A., Eskenazi, B., Barr, D.B., Bravo, R., Castorina, R., Chevrier, J., Kogut, K., Harnly, 
M.E., McKone, T.E., 2005. Organophosphate urinary metabolite levels during preg­
nancy and after delivery in women living in an agricultural community. Environ. 
Health Perspect. 113 (12), 1802–1807. 
Casida, J.E., Durkin, K.A., 2013. Anticholinesterase insecticide retrospective. Chem. Biol. In­
teract. 203 (1), 221–225. http://dx.doi.org/10.1016/j.cbi.2012.08.002. 
CDC (Centers for Disease Control and Prevention), 2009. Fourth National Report on 
Human Exposure to Environmental Chemicals. Centers for Disease Control and Pre­
vention, Atlanta, GA (Retrieved from) http://www.cdc.gov/exposurereport/pdf/ 
FourthReport.pdf (Accessed October 27, 2015). 
CFIA (Canadian Food Inspection Agency), 2009–2010aa. Pesticide Residues and Metals in 
Dried Tea. Canadian Food Inspection Agency, Food safety division, Chemical Evalua­
tion, Ottawa, ON Report. 
CFIA (Canadian Food Inspection Agency), 2008–2009. National Chemical Residue Moni­
toring Program (NCRMP). Canadian Food Inspection Agency, Food safety division, 
Chemical Evaluation, Ottawa, ON Report. 
CFIA (Canadian Food Inspection Agency), 2009–2010bb. National Chemical Residue Mon­
itoring Program (NCRMP). Canadian Food Inspection Agency, Food safety division, 
Chemical Evaluation, Ottawa, ON Report. 
CFIA (Canadian Food Inspection Agency), 2010–2012. National Chemical Residue Moni­
toring Program (NCRMP). Canadian Food Inspection Agency, Food safety division, 
Chemical Evaluation, Ottawa, ON Report. 
Colapinto, C.K., Arbuckle, T.E., Dubois, L., Fraser, W., 2015. Tea consumption in pregnancy 
as a predictor of pesticide exposure and adverse birth outcomes: the MIREC study. 
Environ. Res. 142, 77–83. http://dx.doi.org/10.1016/j.envres.2015.06.020. 
EPA (US Environmental Protection Agency). (2011). Pyrethrins/Pyrethroid Cumulative 
Risk Assessment. Washington, DC: US Environmental Protection Agency, Ofﬁce of 
Pesticide Programs (Retrieved from) http://www.epa.gov/#!documentDetail;D= 
EPA-HQ-OPP-2011-0746-0003N;2011 (Accessed October 27, 2015). 
EPA (US Environmental Protection Agency). Organophosphate Insecticides Recognition 
and Management of Pesticide Poisonnings (Sixth Edition ed.). Washington DC: US 
Environmental Protection Agency, Ofﬁce of Pesticide Programs; 2013. pp. 43–55. 
140 K. Sokoloff et al. / Environment International 94 (2016) 133–140 Eskenazi, B., Harley, K., Bradman, A., Weltzien, E., Jewell, N.P., Barr, D.B., Furlong, C.E., 
Holland, N.T., 2004. Association of in utero organophosphate pesticide exposure 
and fetal growth and length of gestation in an agricultural population. Environ. 
Health Perspect. 112 (10), 1116–1124. 
Eskenazi, B., Marks, A.R., Bradman, A., Harley, K., Barr, D.B., Johnson, C., Morga, N., Jewell, 
N.P., 2007. Organophosphate pesticide exposure and neurodevelopment in young 
Mexican-American children. Environ. Health Perspect. 115 (5), 792–798. http://dx. 
doi.org/10.1289/ehp.9828. 
Garﬁtt, S.J., Jones, K., Mason, H.J., Cocker, J., 2002. Exposure to the organophosphate diaz­
inon: data from a human volunteer study with oral and dermal doses. Toxicol. Lett. 
134 (1–3), 105–113. 
Gonzalez-Alzaga, B., Lacasana, M., Aguilar-Garduno, C., Rodriguez-Barranco, M., Ballester, 
F., Rebagliato, M., Hernandez, A.F., 2013. A systematic review of neurodevelopmental 
effects of prenatal and postnatal organophosphate pesticide exposure. Toxicol. Lett. 
http://dx.doi.org/10.1016/j.toxlet.2013.11.019. 
Health Canada, 2010. Report on Human Biomonitoring of Environmental Chemicals in 
Canada; Results of the Canadian Health Measures Survey Cycle 1 (2007–2009). Cana­
dian Health Measures Survey (CHMS)http://www.hc-sc.gc.ca/ewh-semt/pubs/ 
contaminants/chms-ecms/index-eng.php#n5_5. 
Health Canada, 2012. Pest Control Products Sales Report for 2012. Health Canada, Pesti­
cide Management Regulatory Agency (PMRA), Ottawa, ON (Retrieved from) http:// 
www.hc-sc.gc.ca/cps-spc/pubs/pest/_corp-plan/sales-ventes/index-eng.php. 
Health Canada. (2013). Second Report on Human Biomonitoring of Environmental 
Chemicals in Canada: Results of the Canadian Health Measures Survey Cycle 2 
(2009–2011). Retrieved from http://publications.gc.ca/collections/collection_2013/ 
sc-hc/H128-1-10-601-1-eng.pdf English, French. (Accessed October 27, 2015) 
Helsel, D.R., 2012. Statistics for censored environmental data using Minitab and R. Hobo-
ken, New Jersy (USA). 
Jameson, R.R., Seidler, F.J., Slotkin, T.A., 2007. Nonenzymatic functions of acetylcholines­
terase splice variants in the developmental neurotoxicity of organophosphates: 
chlorpyrifos, chlorpyrifos oxon, and diazinon. Environ. Health Perspect. 115 (1), 
65–70. 
Just, A.C., Adibi, J.J., Rundle, A.G., Calafat, A.M., Camann, D.E., Hauser, R., Silva, M.J., Whyatt, 
R.M., 2010. Urinary and air phthalate concentrations and self-reported use of person­
al care products among minority pregnant women in New York city. J Expo Sci Envi­
ron Epidemiol 20 (7), 625–633. http://dx.doi.org/10.1038/jes.2010.13. 
Kamphuis, C.B., Giskes, K., de Bruijn, G.J., Wendel-Vos, W., Brug, J., van Lenthe, F.J., 2006. 
Environmental determinants of fruit and vegetable consumption among adults: a 
systematic review. Br J Nutr 96 (4), 620–635. 
Kongtip, P., Sasrisuk, S., Preklang, S., Yoosook, W., Sujirarat, D., 2013. Assessment of occu­
pational exposure to malathion and bifenthrin in mosquito control sprayers through 
dermal contact. J. Med. Assoc. Thail. 96 (Suppl. 5), S82–S91. 
Koutroulakis, D., Sifakis, S., Tzatzarakis, M.N., Alegakis, A.K., Theodoropoulou, E., 
Kavvalakis, M.P., Kappou, D., Tsatsakis, A.M., 2014. Dialkyl phosphates in amniotic 
ﬂuid as a biomarker of fetal exposure to organophosphates in Crete, Greece; associa­
tion with fetal growth. Reprod. Toxicol. 46, 98–105. http://dx.doi.org/10.1016/j. 
reprotox.2014.03.010. 
Krieger, R.I., Chen, L., Ginevan, M., Watkins, D., Cochran, R.C., Driver, J.H., Ross, J.H., 2012. 
Implications of estimates of residential organophosphate exposure from 
dialkylphosphates (DAPs) and their relevance to risk. Regul. Toxicol. Pharmacol. 64 
(2), 263–266. http://dx.doi.org/10.1016/j.yrtph.2012.08.012. 
Lauder, J.M., Schambra, U.B., 1999. Morphogenetic roles of acetylcholine. Environ. Health 
Perspect. 107 (Suppl. 1), 65–69. 
McKelvey, W., Jacobson, J.B., Kass, D., Barr, D.B., Davis, M., Calafat, A.M., Aldous, K.M., 2013. 
Population-based biomonitoring of exposure to organophosphate and pyrethroid 
pesticides in New York City. Environ. Health Perspect. 121 (11−12), 1349–1356. 
http://dx.doi.org/10.1289/ehp.1206015. 
Moya, J., Phillips, L., Sanford, J., Wooton, M., Gregg, A., Schuda, L., 2014. A review of phys­
iological and behavioral changes during pregnancy and lactation: potential exposure 
factors and data gaps. J Expo Sci Environ Epidemiol http://dx.doi.org/10.1038/jes. 
2013.92. 
Nauen, R., Elbert, A., McCaffery, A., Slater, R., TC, S., 2012. IRAC: Insecticide Resistance, and 
Mode of Action Classiﬁcation of Insecticides. In: Krämer, W., Schirmer, U., Jeschke, P., Witschel, M. (Eds.), Modern Crop Protection Compounds, second ed. Vol. 3. Wiley-
VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 935–955. 
Nolan, R.J., Rick, D.L., Freshour, N.L., Saunders, J.H., 1984. Chlorpyrifos: pharmacokinetics 
in human volunteers. Toxicol. Appl. Pharmacol. 73 (1), 8–15. 
Oates, L., Cohen, M., Braun, L., Schembri, A., Taskova, R., 2014. Reduction in urinary organ­
ophosphate pesticide metabolites in adults after a week-long organic diet. Environ. 
Res. 132, 105–111. http://dx.doi.org/10.1016/j.envres.2014.03.021. 
Raine, K.D., 2005. Determinants of healthy eating in Canada: an overview and synthesis. 
Can J. Public Health 96 (Suppl 3) S8-14–s8-5. 
Rauch, S.A., Braun, J.M., Barr, D.B., Calafat, A.M., Khoury, J., Montesano, A.M., Yolton, K., 
Lanphear, B.P., 2012. Associations of prenatal exposure to organophosphate pesticide 
metabolites with gestational age and birth weight. Environ. Health Perspect. 120 (7), 
1055–1060. http://dx.doi.org/10.1289/ehp.1104615. 
Slotkin, T.A., 2004. Cholinergic systems in brain development and disruption by 
neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. 
Appl. Pharmacol. 198 (2), 132–151. http://dx.doi.org/10.1016/j.taap.2003.06.001. 
Slotkin, T.A., Seidler, F.J., 2007. Comparative developmental neurotoxicity of organophos­
phates in vivo: transcriptional responses of pathways for brain cell development, cell 
signaling, cytotoxicity and neurotransmitter systems. Brain Res. Bull. 72 (4–6), 
232–274. http://dx.doi.org/10.1016/j.brainresbull.2007.01.005. 
Spaan, S., Pronk, A., Koch, H.M., Jusko, T.A., Jaddoe, V.W., Shaw, P.A., Tiemeier, H.M., 
Hofman, A., Pierik, F.H., Longnecker, M.P., 2015. Reliability of concentrations of organ­
ophosphate pesticide metabolites in serial urine specimens from pregnancy in the 
generation R study. J Expo Sci Environ Epidemiol 25 (3), 286–294. http://dx.doi. 
org/10.1038/jes.2014.81. 
Sudakin, D.L., Stone, D.L., 2011. Dialkyl phosphates as biomarkers of organophosphates: 
the current divide between epidemiology and clinical toxicology. Clin Toxicol 
(Phila) 49 (9), 771–781. http://dx.doi.org/10.3109/15563650.2011.624101. 
Valcke, M., Samuel, O., Bouchard, M., Dumas, P., Belleville, D., Tremblay, C., 2006. Biologi­
cal monitoring of exposure to organophosphate pesticides in children living in peri­
urban areas of the province of Quebec, Canada. Int. Arch. Occup. Environ. Health 79 
(7), 568–577. http://dx.doi.org/10.1007/s00420-006-0085-8. 
van Balen, E.C., Wolansky, M.J., Kosatsky, T., 2012. Increasing use of pyrethroids in Cana­
dian households: should we be concerned? Can J. Public Health 103 (6), e404–e407. 
Wang, P., Tian, Y., Wang, X.J., Gao, Y., Shi, R., Wang, G.Q., Hu, G.H., Shen, X.M., 2012. Organ­
ophosphate pesticide exposure and perinatal outcomes in shanghai. China. Environ 
Int 42 (0), 100–104. http://dx.doi.org/10.1016/j.envint.2011.04.015. 
Wessels, D., Barr, D.B., Mendola, P., 2003. Use of biomarkers to indicate exposure of chil­
dren to organophosphate pesticides: implications for a longitudinal study of 
children's environmental health. Environ. Health Perspect. 111 (16), 1939–1946. 
WHO (World Health Organization), 1986. Biological half-life by route of exposure. In: In 
World Health Organization (Ed.), Environmental health criteria 63: Organophospho­
rus insecticides, a general introduction. Geneva : Albany, N.Y.: World Health Organi­
zation, WHO Publications Center USA, Geneva : Albany, N.Y., p. 181. 
Woodruff, T.J., Zota, A.R., Schwartz, J.M., 2011. Environmental chemicals in pregnant 
women in the United States: NHANES 2003-2004. Environ. Health Perspect. 119 
(6), 878–885. http://dx.doi.org/10.1289/ehp.1002727. 
Ye, M., Beach, J., Martin, J.W., Senthilselvan, A., 2015. Associations between dietary factors 
and urinary concentrations of organophosphate and pyrethroid metabolites in a Ca­
nadian general population. Int. J. Hyg. Environ. Health 218 (7), 616–626. http://dx. 
doi.org/10.1016/j.ijheh.2015.06.006. 
Ye, X., Pierik, F.H., Hauser, R., Duty, S., Angerer, J., Park, M.M., Burdorf, A., Hofman, A., 
Jaddoe, V.W., Mackenbach, J.P., Steegers, E.A., Tiemeier, H., Longnecker, M.P., 2008. 
Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, 
and phthalates among pregnant women in Rotterdam, the Netherlands: the genera­
tion R study. Environ. Res. 108 (2), 260–267. http://dx.doi.org/10.1016/j.envres.2008. 
07.014. 
Zhang, Y., Han, S., Liang, D., Shi, X., Wang, F., Liu, W., Zhang, L., Chen, L., Gu, Y., Tian, Y., 
2014. Prenatal exposure to organophosphate pesticides and neurobehavioral devel­
opment of neonates: a birth cohort study in Shenyang, China. PLoS One 9 (2), 
e88491. http://dx.doi.org/10.1371/journal.pone.0088491. 
